These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 2836153
1. Enzyme activities of collagen peptidase (CP), monoaminoxidase (MAO) and N-acetyl-beta-D-glucosaminidase (beta-NAG) as fibrosis marker in chronic liver diseases. Müller A, Zollmann C, Machnik G, Krombholz B, Reinhardt M, Jorke D. Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):27-34. PubMed ID: 2836153 [Abstract] [Full Text] [Related]
2. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Schneider M, Voss B, Högemann B, Eberhardt G, Gerlach U. Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303 [Abstract] [Full Text] [Related]
6. [Activity of beta-N-acetylglucosaminidase in chronic alcoholic liver disease]. Pinto C, Galvão-Teles A, Monteiro E, Marques C, Azevedo M, Manso C. Acta Med Port; 1990 Jan; 3(2):75-9. PubMed ID: 2349891 [Abstract] [Full Text] [Related]
14. The effect of elective surgery on serum N-acetyl-beta-D-glucosaminidase activity. Harju E, Ehrola P, Koivula T. Acta Physiol Hung; 1990 Jan; 76(3):237-43. PubMed ID: 2100103 [Abstract] [Full Text] [Related]
17. [N-acetyl-beta-D-glucosaminidase as an early marker and indicator of the extent of kidney and liver lesions in endotoxemia and endotoxic shock]. Martinović S, Filipović N, Hadzić N, Pikula B. Acta Med Iugosl; 1991 Jan; 45(2):111-21. PubMed ID: 1887806 [Abstract] [Full Text] [Related]
19. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C. Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J. Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291 [Abstract] [Full Text] [Related]